Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01628315 · ClinicalTrials.gov registry record
Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 159
- Enrollment target
NCT01628315 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 159 participants.
The verdict
NCT01628315 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 159 participants
- Enrollment target
Study Summary
* To examine short- and long-term value of appearance of new active lesions in predicting extent of cortical and subcortical deep gray matter (SDGM) atrophy over 5 years in ASA (Avonex- Steroid-Azathioprine)study. * To explore how accumulation of cortical and SDGM atrophy over 5 years differs with respect to the number of new active lesions or amount of disease activity, in early relapsing-remitting multiple sclerosis (RRMS) patients who did or did not develop sustained disability progression. * To examine the relationship between development of cortical and SDGM atrophy and regional likelihood of development of new active lesions over 5 years.
Interventions
- DEVICE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01628315
The ClinicalTrials.gov registry entry for NCT01628315 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT01628315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01628315 about?
NCT01628315 is a clinical study titled "Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study". * To examine short- and long-term value of appearance of new active lesions in predicting extent of cortical and subcortical deep gray matter (SDGM) atrophy over 5 years in ASA (Avonex- Steroid-Azathioprine)study. * To explore how accumulation of cortical and SDGM atrophy over 5 years differs with r...
What is the current status of trial NCT01628315?
This trial is currently completed. The enrollment target is 159 participants. The study started on 2009-03. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01628315?
The interventions under investigation include: MRI (DEVICE).
Who is sponsoring clinical trial NCT01628315?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.